Jean-Claude Provost, MD

Jean-Claude Provost, MD

Chief Science OfficeratLantheus Holdings· In proxies 2023–2024

Pay in FY2024+13% from the year before · Lantheus Holdings stock +44.3% the same year

Jean-Claude Provost, MD was paid $3.5M in FY2024 (Dec), up 13%. Lantheus Holdings stock rose 44.3% that year.

Pay$100 in the stock at the end of FY22 → $176
Pay is from the Summary Compensation Table of each Lantheus Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Lantheus HoldingsPublic company · 3 yr
    • Chief Science Officer2023 – Present · 3 yrStock in role +104%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?